ohara c ( mph ), murata a ( md ), inoue m ( md,phd ), inoue k ( md,phd ) persons...

1
M MD,PhD , Inoue K MD,PhD profiles of cardiovascular and metabolic predictors than those with known diabetes. Undiagnosed diabetes should also be recognized as a condition with these risks. 0 5 10 15 20 25 30 35 40 45 50 NRS(n 23490)% IFG(n 8787)% Known Diabetes(n 911)% Undiagnosed Diabetes(n 1089)% Table1 Subject Characteristics Figure1 Frequencies of subjects who had worse profiles of cardiovascular and metabolic markers according to the four categories Table2 Comparison of cardiovascular and metabolic markers between known and undiagnosed diabetes according to age (<60.5, 60.5 years) Table3 Comparison of cardiovascular and metabolic markers between known/poor control (HbA1c >=7.0%) and undiagnosed POINT Table1&Figure1 Table2 Table3 Undiagnosed diabetes has worse profiles of cardiovascular and metabolic markers than known diabetes Tosa Danji MD, PhD), Tosa Danji MD, PhD), Tosa Danji MD, PhD), Tosa Danji MD, PhD), Department of Inoue Methods, Kada Medical Center, IM University School of Medicine, Japan Introduction Results Methods Design: Setting &Period: Purpose of this study Discussion Conclusion [email protected] Address: 8-8-8 Doraemon-City, Tokyo, Japan N=23,491 NFG (Normal Fasting Glucose) FPG<100 N=8,786 IFG (Impaired Fasting Glucose) 100 FPG 125 N=63103 persons Excluded N=34,282 persons Eligible for analysis N=97,585 persons Aged 23-64 years April 1998 –march 2006 N=1089 Undiagnosed Diabetes FPG 126 N=795 Known Diabetes FPG 126 Characteristics NFG IFG Known Diabetes Undiagnosed Diabetes P value adjusted by Sex Age BMI n 23491 n 8786 n 916 n 1089 4 groups 2groups Known vs Undiagnose d Fasting plasma glucose (mol/l) 5.0±0.32 5.9±0.3 8.0±2.4 8.9±2.3 <.0001 <.0001 HbA1c (%) 4.8±0.4 5.2±0.5 6.9±1.6 7.1±1.8 <.0001 <.0001 Age (years) 49.8 ±13.3 55.3±11.6 60.3±8.0 58.6±10.4 Male sex, n (%) 9879 42.1) 5779(65.8) 650(71.3) 781(71.7) BMI (kg/m2) 22.3±2.9 24.0±3.1 23.9±3.1 24.9±3.5 Systolic blood pressure (mmHg) 120±17 131±18 131±17 137±19 <.0001 <.0001 Diastolic blood pressure (mmHg) 73±11 80±11 78±10 83±11 <.0001 <.0001 Triglycerides (mmol/l) 0.93(0.67to1.35 ) 1.24(0.89to1. 79) 1.33(0.92to1. 85) 1.54(1.07to2.30 ) <.0001 <.0001 Total cholesterol (mmol/l) 199.6±35.1 208.1±35.4 202.0±34.4 214.0±38.1 <.0001 <.0001 HDL cholesterol (mmol/l) 59.1±14.8 54.5±14.0 52.3±13.8 51.1±12.7 <.0001 <.0001 Asparate aminotransferase (U/l) 20.0(17to24) 22.0(19to27) 22(18to27) 24(19to31) <.0001 <.0001 Alanine aminotransferase (U/l) 17(13to23) 21(16to32) 22(16to32) 26(19to39) <.0001 <.0001 γ -Glutamyltranspeptidase (U/l) 17(11to28) 26(16to47) 25(15to46) 38(23to72) <.0001 <.0001 Uric acid 5.1±1.3 5.8±1.4 5.4±1.3 5.6±1.4 <.0001 <.0001 Data are expressed as mean ± SD, median (25th percentile, 75th percentile) or number (%). For comparison of means, triglycerides, asparate aminotransferase, alanine aminotransferase, γ- glutamyltranspeptidase were log transformed for their skewed distributions. Age <60.5 years 60.5 years Known DM n=435 Undiagnosed DM n 580 P value Known DM n=479 Undiagnosed DM n=509 P value Fasting plasma glucose (mmol/l) 8.2±2.6 9.0±2.4 <.000 1 7.8± 2.2 8.8±2.2 <.0001 HbA1c (%) 6.8± 2.1 7.1± 1.9 0.15 6.8± 1.5 7.0±1.6 0.006 BMI (kg/m2) 24.0± 4.0 25.3± 3.8 <.000 1 23.6± 2.8 24.5± 3.1 <.0001 Systolic blood pressure (mmHg) 128.2± 17.9 134.8± 19.3 <.000 1 133.6± 16.5 139.2± 18.3 <.0001 Diastolic blood pressure (mmHg) 77.8± 10.7 82.9± 11.9 <.000 1 78.2± 9.8 82.2± 11.3 <.0001 Triglycerides (mmol/l) 1.74±1.6 2.1± 1.5 0.000 2 1.4± 0.7 1.6± 0.9 <.0001 Total cholesterol (mmol/l) 202.9± 37.2 217.7± 40.0 <.000 1 200.8± 32.9 209.8± 35.5 <.0001 HDL cholesterol (mmol/l) 51.6± 14.3 50.3± 12.1 0.09 53.3± 13.9 52.0± 13.2 0.17 Asparate aminotransferase (U/l) 22(18to2 8) 24(19to32) 0.000 3 21(18to26) 23(20to29) 0.001 Alanine aminotransferase (U/l) 24(17to3 8) 29(20to44) <.000 1 20(16to28) 32(19to55) <.0001 γ -Glutamyltranspeptidase (U/l) 30(18to5 8) 46(27to90) <.000 1 22(14to35) 32(19to55) <.0001 HbA1c Known DM n=355 Undiagnosed DM n=430 P value Fasting plasma glucose (mmol/l) 9.9±2.5 10.8±2.6 <.0001 BMI (kg/m2) 24.0± 3.2 24.9±3.7 0.0004 Systolic blood pressure (mmHg) 131.4± 18.2 135.2± 18.1 0.003 Diastolic blood pressure (mmHg) 78.1± 10.5 80.9± 10.8 0.0003 Triglycerides (mmol/l) 1.4(0.9to1.9) 1.5(1.1to2.3) 0.01 Total cholesterol (mmol/l) 205.6±37.5 214.0± 38.2 0.0002 HDL cholesterol (mmol/l) 51.2± 13.7 51.1± 13.3 0.02 Asparate aminotransferase (U/l) 21(17to29) 23(19to30) 0.04 Alanine aminotransferase (U/l) 22(17to37) 27(19to39) 0.009 γ - Glutamyltranspeptidase (U/l) 27(16to52) 37(23to67) <.0001

Upload: cameron-randall

Post on 01-Jan-2016

213 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Ohara C ( Mph ), Murata A ( MD ), Inoue M ( MD,PhD ), Inoue K ( MD,PhD ) Persons with undiagnosed diabetes have worse profiles of cardiovascular and metabolic

Ohara C( Mph) , Murata  A( MD) , Inoue M( MD,PhD) ,  Inoue K(MD,PhD)

Persons with undiagnosed diabetes have worse profiles of cardiovascular and metabolic predictors than those with known diabetes. Undiagnosed diabetes

should also be recognized as a condition with these risks.

BMI

Systo

licbloodpres

sure

Diastri

cbloodbpres

sure

trigly

cerides

Total

choles

terol

HDLcholes

terol

Aspara

teaminotra

nsferas

e

Alaninea

minotransfe

rase

y-Glutam

yltran

soep

tidase0

5

10

15

20

25

30

35

40

45

50

NRS(n= 23490)%

IFG(n= 8787)%

Known Diabetes(n= 911)%

Undiagnosed Diabetes(n= 1089)%

 

Table1 Subject Characteristics Figure1 Frequencies of subjects who had worse profiles of cardiovascular and metabolic markers according to the four categories

Table2 Comparison of cardiovascular and metabolic markers between known and undiagnosed diabetes according to age (<60.5, 60.5 years)≧

Table3 Comparison of cardiovascular and metabolic markers between known/poor control (HbA1c >=7.0%) and undiagnosed diabetes  

POINT・ Table1&Figure1

・ Table2

・ Table3

  Undiagnosed diabetes has worse profiles of cardiovascular and metabolic markers than known diabetes

Tosa Danji(MD, PhD), Tosa Danji(MD, PhD), Tosa Danji(MD, PhD), Tosa Danji(MD, PhD),Department of Inoue Methods, Kada Medical Center, IM University School of Medicine, Japan

Introduction Results

MethodsDesign: Setting &Period:

Purpose of this study

Discussion

Conclusion

[email protected] Address: 8-8-8 Doraemon-City, Tokyo, Japan

N=23,491 

NFG(Normal  Fasting Glucose)

FPG<100

N=8,786

IFG(Impaired Fasting Glucose)

100 FPG≦ > 125

N=63103 persons Excluded

N=34,282 personsEligible for analysis

N=97,585 persons Aged 23-64 years

April 1998 –march 2006

N=1089

Undiagnosed Diabetes

FPG 126≧

N=795

Known Diabetes

FPG 126≧

Characteristics NFG IFG Known Diabetes

Undiagnosed

Diabetes 

P value

adjusted by Sex Age BMI

  n= 23491 n= 8786 n= 916  n= 1089 4 groups

2groups Known vs Undiagnos

ed

Fasting plasma glucose (mol/l)

5.0±0.32 5.9±0.3 8.0±2.4 8.9±2.3 <.0001 <.0001

HbA1c (%) 4.8±0.4 5.2±0.5 6.9±1.6 7.1±1.8 <.0001 <.0001

Age (years) 49.8 ±13.3 55.3±11.6 60.3±8.0 58.6±10.4    

Male sex, n (%) 9879〈 42.1) 5779(65.8) 650(71.3) 781(71.7)    

BMI (kg/m2) 22.3±2.9 24.0±3.1 23.9±3.1 24.9±3.5    

Systolic blood pressure (mmHg)

120±17 131±18 131±17 137±19 <.0001 <.0001

Diastolic blood pressure (mmHg)

73±11 80±11 78±10 83±11 <.0001 <.0001

Triglycerides (mmol/l) 0.93(0.67to1.35)

1.24(0.89to1.79)

1.33(0.92to1.85)

1.54(1.07to2.30)

<.0001 <.0001

Total cholesterol (mmol/l) 199.6±35.1 208.1±35.4 202.0±34.4 214.0±38.1 <.0001 <.0001

HDL cholesterol (mmol/l) 59.1±14.8 54.5±14.0 52.3±13.8 51.1±12.7 <.0001 <.0001

Asparate aminotransferase (U/l)

20.0(17to24) 22.0(19to27) 22(18to27) 24(19to31) <.0001 <.0001

Alanine aminotransferase (U/l)

17(13to23) 21(16to32) 22(16to32) 26(19to39) <.0001 <.0001

γ -Glutamyltranspeptidase (U/l)

17(11to28) 26(16to47) 25(15to46) 38(23to72) <.0001 <.0001

Uric acid 5.1±1.3 5.8±1.4 5.4±1.3 5.6±1.4 <.0001 <.0001Data are expressed as mean ± SD, median (25th percentile, 75th percentile) or number (%). For comparison of means, triglycerides, asparate aminotransferase, alanine aminotransferase, γ-glutamyltranspeptidase were log transformed for their skewed distributions.

  Age  <60.5 years ≧60.5  years

 Known

DMn=435

Undiagnosed DM

n= 580

P value

Known DMn=479

Undiagnosed DMn=509

P value

Fasting plasma glucose (mmol/l) 8.2±2.6 9.0±2.4 <.000

1 7.8± 2.2 8.8±2.2 <.0001

HbA1c (%) 6.8± 2.1 7.1± 1.9 0.15 6.8± 1.5 7.0±1.6 0.006

BMI (kg/m2)24.0±

4.0 25.3± 3.8 <.0001 23.6± 2.8 24.5± 3.1 <.000

1

Systolic blood pressure (mmHg)

128.2± 17.9

134.8± 19.3

<.0001

133.6± 16.5

139.2± 18.3

<.0001

Diastolic blood pressure (mmHg)

77.8± 10.7 82.9± 11.9 <.000

1 78.2± 9.8 82.2± 11.3 <.0001

Triglycerides (mmol/l) 1.74±1.6 2.1± 1.5 0.0002 1.4± 0.7 1.6± 0.9 <.000

1

Total cholesterol (mmol/l) 202.9±

37.2217.7±

40.0<.000

1200.8±

32.9209.8±

35.5<.000

1

HDL cholesterol (mmol/l) 51.6± 14.3 50.3± 12.1 0.09 53.3± 13.9 52.0± 13.2 0.17

Asparate aminotransferase (U/l)

22(18to28) 24(19to32) 0.000

3 21(18to26) 23(20to29) 0.001

Alanine aminotransferase (U/l)

24(17to38) 29(20to44) <.000

1 20(16to28) 32(19to55) <.0001

γ -Glutamyltranspeptidase (U/l)

30(18to58) 46(27to90) <.000

1 22(14to35) 32(19to55) <.0001

  HbA1c  

  Known DMn=355

Undiagnosed  DM n=430

P value

Fasting plasma glucose (mmol/l) 9.9±2.5 10.8±2.6 <.0001

BMI (kg/m2) 24.0± 3.2 24.9±3.7 0.0004

Systolic blood pressure (mmHg) 131.4± 18.2 135.2± 18.1 0.003

Diastolic blood pressure (mmHg) 78.1± 10.5 80.9± 10.8 0.0003

Triglycerides (mmol/l) 1.4(0.9to1.9) 1.5(1.1to2.3) 0.01

Total cholesterol (mmol/l) 205.6±37.5 214.0± 38.2 0.0002

HDL cholesterol (mmol/l) 51.2± 13.7 51.1± 13.3 0.02

Asparate aminotransferase (U/l) 21(17to29) 23(19to30) 0.04

Alanine aminotransferase (U/l) 22(17to37) 27(19to39) 0.009

γ -Glutamyltranspeptidase (U/l)

27(16to52) 37(23to67) <.0001

Cube i7
Table2 Comparison of cardiovascular and metabolic markers between known and undiagnosed diabetes according to age (<53, >53 years)
Cube i7
Table3 Comparison of cardiovascular and metabolic markers between known/poor control (HbA1c >=7.0%) and undiagnosed diabetes
user03
Setting &Period: We used a dataset derived from the health screening program performed by the Yuport Medical Checkup Center in Tokyo for April 1998 to 2006. In total, 97,585 persons (age: 24-64 years) participated in this health check-up. For repeated participants, data of the first visit was used, and finally data of 34,282 persons was used for the analysis.